A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors

BMJ Open - Tập 7 Số 8 - Trang e016621 - 2017
P Jacklin1, Michael Maresh2, Christopher Patterson3, Katharine P. Stanley4, Anne Dornhorst5, S. Burman-Roy1, Rudy Bilous6
1Royal College of Obstetricians and Gynaecologists, London, UK
2St. Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
3Centre for Public Health, Queen’s University Belfast, Belfast, UK
4Department of Obstetrics and Gynaecology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
5Department of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, UK
6Newcastle University Medicine Malaysia, Johor, Malaysia

Tóm tắt

ObjectivesTo compare the cost-effectiveness (CE) of the National Institute for Health and Care Excellence (NICE) 2015 and the WHO 2013 diagnostic thresholds for gestational diabetes mellitus (GDM).SettingThe analysis was from the perspective of the National Health Service in England and Wales.Participants6221 patients from four of the Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) study centres (two UK, two Australian), 6308 patients from the Atlantic Diabetes in Pregnancy study and 12 755 patients from UK clinical practice.Primary and secondary outcome measures plannedThe incremental cost per quality-adjusted life year (QALY), net monetary benefit (NMB) and the probability of being cost-effective at CE thresholds of £20 000 and £30 000 per QALY.ResultsIn a population of pregnant women from the four HAPO study centres and using NICE-defined risk factors for GDM, diagnosing GDM using NICE 2015 criteria had an NMB of £239 902 (relative to no treatment) at a CE threshold of £30 000 per QALY compared with WHO 2013 criteria, which had an NMB of £186 675. NICE 2015 criteria had a 51.5% probability of being cost-effective compared with the WHO 2013 diagnostic criteria, which had a 27.6% probability of being cost-effective (no treatment had a 21.0% probability of being cost-effective). For women without NICE risk factors in this population, the NMBs for NICE 2015 and WHO 2013 criteria were both negative relative to no treatment and no treatment had a 78.1% probability of being cost-effective.ConclusionThe NICE 2015 diagnostic criteria for GDM can be considered cost-effective relative to the WHO 2013 alternative at a CE threshold of £30 000 per QALY. Universal screening for GDM was not found to be cost-effective relative to screening based on NICE risk factors.

Từ khóa


Tài liệu tham khảo

10.1056/NEJMoa0707943

10.1136/bmj.i4694

10.2337/dc10-0719

WHO Health organisation. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy WHO/NMH/MND/13.2. 2013 http://apps.who.int/iris/bitstream/10665/85975/1/WHO_NMH_MND_13.2_eng.pdf.

10.1097/01.AOG.0000433006.09219.f1

National Institute for Health and Care Excellence (NICE). Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. Clinical guideline NG3 (2015). 2015 www.nice.org.uk/guidance/ng3/resources/diabetes-in-pregnancy-management-of-diabetes-and-itscomplications-from-preconception-to-the-postnatal-period-51038446021 (accessed Feb 2016).

Meek, 2015, Diagnosis of gestational diabetes mellitus: falling through the net, Diabetologia, 58, 2003, 10.1007/s00125-015-3647-z

10.2337/dc14-0179

10.2337/dc14-1232

10.3310/hta20220

10.1056/NEJMoa042973

10.1056/NEJMoa0902430

10.1136/bmj.c1395

10.1007/s00125-010-1881-y

National Institute for Health and Care Excellence. Developing NICE guidelines: the manual. 2014 https://www.nice.org.uk/media/default/about/what-we-do/our-programmes/developing-nice-guidelines-the-manual.pdf.

Briggs A , Claxton K , Sculpher M . Decision modelling for Health Economic evaluation. Oxford: Oxford University Press, 2006.

10.2337/dc12-2669

10.2337/dc13-0833

Armstrong R , Waters E , Doyle J . The Cochrane Collaboration. Reviews in health promotion and public health. In: Higgins JPT , Green S , eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011, 2011. www.cochrane-handbook.org. (Accessed June 2015).

10.2337/dc11-1643

10.1111/dme.12625

10.2337/dc14-2159

Thông tin
Thông tin xuất bản

BMJ Open

Tập 7 Số 8

e016621

Thông tin tác giả